메뉴 건너뛰기




Volumn 320, Issue 9, 2018, Pages 867-868

Real-world evidence and real-world data for evaluating drug safety and effectiveness

Author keywords

[No Author keywords available]

Indexed keywords

BLINATUMOMAB;

EID: 85052708425     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2018.10136     Document Type: Review
Times cited : (301)

References (6)
  • 1
    • 84981719116 scopus 로고    scopus 로고
    • The Emergence of the randomized, controlled trial
    • Bothwell LE, Podolsky SH. The Emergence of the randomized, controlled trial. N Engl J Med. 2016; 375(6):501-504. doi:10.1056/NEJMp1604635
    • (2016) N Engl J Med , vol.375 , Issue.6 , pp. 501-504
    • Bothwell, L.E.1    Podolsky, S.H.2
  • 2
    • 85053001582 scopus 로고    scopus 로고
    • Section 3022. 21 USC §
    • Section 3022. 21st Century Cures Act, 21 USC §355g.
    • 21st Century Cures Act , pp. 355g
  • 3
    • 77950493245 scopus 로고    scopus 로고
    • website. Accessed July 25, 2018
    • Sentinel. Sentinel Initiative website. https://www.sentinelinitiative.org/. Accessed July 25, 2018.
    • Sentinel Initiative
  • 4
    • 85014429789 scopus 로고    scopus 로고
    • Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia
    • Gökbuget N, Kelsh M, Chia V, et al. Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia. Blood Cancer J. 2016;6(9):e473. doi:10.1038/bcj.2016.84
    • (2016) Blood Cancer J , vol.6 , Issue.9 , pp. e473
    • Gökbuget, N.1    Kelsh, M.2    Chia, V.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.